Live Breaking News & Updates on Zenyaku Holdings Co Ltd

Stay updated with breaking news from Zenyaku holdings co ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ASLAN Pharmaceuticals : receives US$12,000,000 from Zenyaku Kogyo

ASLAN Pharmaceuticals receives US$12,000,000 from Zenyaku Kogyo

On July 20, 2023, ASLAN Pharmaceuticals Limited announced that it had received the sum of US$12,000,000 from. ....

Zenyaku Kogyo , Company Us Securities , Zenyaku Holdings Co Ltd , Company Annual Report On Form , Company Registration Statement On Form , Exchange Commission , Exchange Commission On , Pharmaceuticals Limited The Company , Zenyaku Kogyo Co Ltd , Commission File No , Registration Statement , Strategic Licensing Agreement , Commission File , Annual Report ,

ASLAN Pharmaceuticals : Second Quarter 2023 Cash Update

Second Quarter 2023 Cash Update

Based on current estimates, as of June 30, 2023, ASLAN Pharmaceuticals Limited had cash and cash equivalents of $40.9 million.. ....

Pharmaceuticals Limited The Company , Zenyaku Kogyo Co Ltd , American Depositary Shares Of The Company Adss , Company Registration Statement On Form , Exchange Commission , Zenyaku Holdings Co Ltd , Walkers Singapore Limited Liability Partnership , Second Quarter , Open Market Sale , American Depositary Shares , Securities Act , Prospectus Supplement , Limited Liability Partnership , Sale Agreement , Registration Statement ,

ASLAN Pharmaceuticals Enters Into a Strategic Licensing Deal With Zenyaku Kogyo for the Development and Commercialization of Eblasakimab in Japan

ASLAN will receive up to $15 million in upfront and near-term payments and up to an additional $123.5 million based on development and commercial milestones plus tiered royalties on sales in percentages ranging up to low twentiesZenyaku Kogyo, a leading J. ....

United States , Ashleyr Robinson , Carl Firth , Koichi Hashimoto , Emma Thompson , Zenyaku Kogyo , Chugai Pharmaceutical Co Ltd , Pharmaceuticals Nasdaq , Decision Resources Group , Globenewswire Inc , Zenyaku Kogyo Co Ltd , Zenyaku Holdings Co Ltd , Zenyaku Holdings , Company Annual Report On Form , Commission File No , Spurwing Communications , Exchange Commission , Lifesci Advisors , Chief Executive Officer , B Cell Non Hodgkin , Commission File , Annual Report , Resources Group , Atopic Dermatitis Disease Landscape , Sci Advisors ,